caffeine has been researched along with Complete Trisomy 18 Syndrome in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Central apnea is a major cause of death in neonates with trisomy 18 (T18) and is likely due to immaturity of the respiratory drive, similar to the pathological mechanism in apnea of prematurity." | 8.12 | Caffeine for the Treatment of Central Apnea in Trisomy 18: A Case Study in the Novel Use of Methylxanthines in Palliative Transport. ( Andersen, L; Ariagno, S; Collura, C; Thorvilson, M, 2022) |
"Central apnea is a major cause of death in neonates with trisomy 18 (T18) and is likely due to immaturity of the respiratory drive, similar to the pathological mechanism in apnea of prematurity." | 4.12 | Caffeine for the Treatment of Central Apnea in Trisomy 18: A Case Study in the Novel Use of Methylxanthines in Palliative Transport. ( Andersen, L; Ariagno, S; Collura, C; Thorvilson, M, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ariagno, S | 1 |
Thorvilson, M | 1 |
Andersen, L | 1 |
Collura, C | 1 |
Smith, A | 1 |
Egan, R | 1 |
Boyle, MA | 1 |
McElligott, F | 1 |
2 other studies available for caffeine and Complete Trisomy 18 Syndrome
Article | Year |
---|---|
Caffeine for the Treatment of Central Apnea in Trisomy 18: A Case Study in the Novel Use of Methylxanthines in Palliative Transport.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Female; Humans; Infant; Infant, Newborn; Infant, | 2022 |
The Use of Caffeine for Apnoea Associated with Trisomy 13 and Trisomy 18.
Topics: Apnea; Caffeine; Humans; Infant, Newborn; Infant, Premature; Trisomy 13 Syndrome; Trisomy 18 Syndrom | 2021 |